Accurate Diagnostics Labs, INC.

Accurate Diagnostics Labs, INC. was paid $37.43M by Medicaid between Jan 2018 and Dec 2022, across 301 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 29% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#9 of 122

Median peer was paid$1.29M

This provider vs. median29×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	671,621	$5.06M
2019	732,982	$4.74M
2020	741,378	$9.03M
2021	1,043,253	$12.63M
2022	1,117,448	$5.97M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	29%	163,057	131,080	$10.71M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	5.9%	165,879	163,846	$2.20M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	5.4%	108,223	84,352	$2.00M
86769		5.3%	83,528	53,737	$1.97M
80050	General health panel	4.2%	62,110	61,687	$1.58M
80061	Lipid panel	3.3%	265,528	261,966	$1.23M
82607		2.6%	138,787	137,521	$976K
80053	Comprehensive metabolic panel	2.5%	249,953	244,563	$932K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	2.1%	46,700	45,877	$800K
82746		2.0%	114,890	113,948	$767K
83036	Hemoglobin; glycosylated (A1C)	2.0%	208,295	205,580	$754K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	1.8%	14,371	11,584	$677K

289 more codes

87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.8%	46,753	$668K
84443	Thyroid stimulating hormone (TSH)	1.6%	168,847	$590K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.4%	47,357	$531K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.4%	255,416	$523K
86480		1.3%	17,039	$474K
84480		1.2%	79,837	$440K
80074		<1%	17,859	$320K
86003		<1%	7,516	$316K
82728		<1%	53,117	$316K
84153		<1%	35,981	$288K
81001		<1%	196,744	$277K
84439		<1%	69,273	$267K
84436		<1%	78,958	$212K
88142		<1%	16,505	$211K
83013		<1%	6,094	$192K
83550		<1%	57,973	$192K
36415	Collection of venous blood by venipuncture	<1%	271,387	$175K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	16,046	$173K
86141		<1%	26,673	$168K
83540		<1%	65,882	$167K
84154		<1%	19,128	$164K
86780		<1%	25,784	$156K
83735		<1%	54,745	$154K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	11,745	$154K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,545	$150K
86235		<1%	5,347	$149K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	11,605	$144K
84481		<1%	22,326	$143K
86696		<1%	15,040	$141K
87086	Culture, bacterial; quantitative colony count, urine	<1%	41,430	$137K
84403		<1%	10,714	$136K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	4,346	$133K
86803		<1%	23,111	$130K
82043		<1%	55,871	$120K
82652		<1%	10,046	$119K
86706		<1%	20,656	$105K
86038		<1%	20,586	$99K
86618		<1%	5,317	$97K
86376		<1%	13,386	$96K
86704		<1%	15,881	$93K
87340		<1%	18,368	$89K
86762		<1%	11,349	$87K
84550		<1%	45,424	$87K
84402		<1%	6,911	$86K
86695		<1%	14,020	$82K
86800		<1%	11,324	$80K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,205	$77K
86765		<1%	11,231	$77K
80048	Basic metabolic panel (calcium, ionized)	<1%	21,738	$76K
88342		<1%	2,321	$70K
83516		<1%	7,584	$70K
86708		<1%	10,847	$69K
87522	Neg quan hep c or qual rna	<1%	3,291	$64K
86328		<1%	2,267	$62K
82570		<1%	33,363	$59K
83001		<1%	6,363	$59K
80076		<1%	16,413	$58K
85651		<1%	40,794	$57K
86592		<1%	23,529	$57K
86735		<1%	10,416	$57K
82670		<1%	4,069	$56K
86787		<1%	9,277	$54K
84146		<1%	5,603	$54K
83880		<1%	4,722	$54K
83002		<1%	5,690	$52K
83970		<1%	3,668	$50K
88312		<1%	1,331	$48K
83721		<1%	15,625	$46K
86694		<1%	5,571	$41K
86430		<1%	16,196	$41K
82785		<1%	5,239	$40K
86617		<1%	2,426	$40K
87070		<1%	6,927	$39K
82550		<1%	15,984	$39K
84479		<1%	18,596	$38K
84144		<1%	3,627	$37K
88112		<1%	2,108	$36K
87088		<1%	11,254	$36K
84445		<1%	1,324	$35K
84702		<1%	5,376	$35K
83655		<1%	5,304	$34K
82248		<1%	12,926	$34K
87536		<1%	756	$32K
82627		<1%	2,962	$32K
86256		<1%	2,802	$32K
83525		<1%	5,746	$31K
85610		<1%	19,950	$31K
87481		<1%	2,553	$31K
82378		<1%	4,006	$30K
86200		<1%	5,935	$29K
82784		<1%	4,109	$28K
86225		<1%	5,566	$28K
86140		<1%	10,970	$24K
84207		<1%	1,636	$24K
86665		<1%	1,411	$23K
83690		<1%	7,973	$23K
83090		<1%	3,102	$23K
85730		<1%	10,674	$22K
86160		<1%	2,193	$22K
82977		<1%	7,812	$20K
87902		<1%	121	$20K
86677		<1%	3,712	$19K
87517		<1%	1,197	$18K
83615		<1%	6,910	$18K
84425		<1%	2,037	$17K
87511		<1%	2,352	$16K
83520		<1%	2,382	$16K
86255		<1%	3,370	$16K
82150		<1%	5,776	$15K
83921		<1%	1,590	$15K
82274		<1%	4,607	$15K
84378		<1%	3,774	$15K
86334		<1%	1,371	$14K
82105		<1%	3,096	$14K
88141		<1%	1,788	$14K
84100		<1%	7,550	$14K
82553		<1%	2,762	$14K
82533		<1%	1,610	$13K
82172		<1%	2,405	$13K
86060		<1%	4,198	$13K
83883		<1%	1,852	$13K
88304		<1%	1,000	$12K
87186		<1%	3,023	$12K
84681		<1%	1,210	$11K
88313		<1%	548	$11K
84466		<1%	2,427	$11K
82672		<1%	913	$11K
87077		<1%	2,419	$11K
87529		<1%	571	$11K
86664		<1%	1,277	$10K
84703		<1%	2,825	$10K
87653		<1%	1,102	$10K
85027		<1%	5,724	$9K
84270		<1%	1,103	$9K
87338		<1%	1,360	$9K
86304		<1%	1,340	$9K
86632		<1%	1,180	$8K
87486		<1%	568	$8K
87581		<1%	568	$8K
83021		<1%	757	$8K
86147		<1%	389	$8K
86301		<1%	1,294	$8K
82465		<1%	4,550	$8K
86631		<1%	1,181	$8K
80165		<1%	1,307	$8K
86900		<1%	5,292	$8K
86705		<1%	2,682	$8K
86901		<1%	5,297	$8K
87209		<1%	902	$7K
85045		<1%	4,376	$7K
86663		<1%	1,070	$7K
82985		<1%	1,488	$7K
86360		<1%	427	$7K
82947		<1%	3,782	$7K
83010		<1%	1,251	$6K
84165		<1%	1,654	$6K
86709		<1%	2,581	$6K
86431		<1%	1,545	$6K
82272		<1%	3,711	$6K
84478		<1%	3,258	$5K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	124	$5K
87177		<1%	987	$5K
83695		<1%	2,076	$5K
86671		<1%	615	$5K
84630		<1%	1,005	$5K
87660		<1%	406	$4K
83704		<1%	452	$4K
83020		<1%	950	$4K
86317		<1%	434	$4K
87350		<1%	809	$4K
87427		<1%	650	$4K
86707		<1%	759	$4K
84432		<1%	801	$4K
86340		<1%	673	$4K
82103		<1%	614	$3K
82180		<1%	688	$3K
82542		<1%	381	$3K
85379		<1%	808	$3K
84442		<1%	749	$3K
87510		<1%	399	$3K
80320		<1%	1,407	$3K
80177		<1%	747	$3K
87480		<1%	402	$3K
82565		<1%	1,682	$3K
82626		<1%	375	$3K
84156		<1%	2,314	$3K
86644		<1%	599	$3K
87184		<1%	636	$3K
86609		<1%	321	$3K
84460		<1%	1,446	$3K
87046		<1%	668	$3K
84590		<1%	421	$3K
83718		<1%	1,928	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	2,973	$2K
84520		<1%	1,623	$2K
87045		<1%	545	$2K
82390		<1%	520	$2K
88311		<1%	542	$2K
84446		<1%	284	$2K
86850		<1%	1,197	$2K
86300		<1%	348	$2K
82024		<1%	178	$2K
84163		<1%	140	$2K
81596		<1%	65	$2K
83698		<1%	255	$2K
84252		<1%	184	$2K
87205		<1%	925	$2K
84450		<1%	1,109	$2K
83825		<1%	220	$2K
82247		<1%	1,087	$2K
80365		<1%	979	$2K
86336		<1%	109	$2K
86747		<1%	211	$2K
80349		<1%	657	$2K
84155		<1%	1,580	$2K
80051		<1%	587	$2K
86645		<1%	434	$2K
83519		<1%	239	$1K
82164		<1%	260	$1K
80178		<1%	305	$1K
85660		<1%	305	$1K
87493		<1%	127	$1K
84484		<1%	289	$1K
80185		<1%	163	$1K
87081		<1%	163	$1K
81025		<1%	379	$1K
81374		<1%	85	$1K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	371	$1K
87625		<1%	145	$1K
87324		<1%	171	$998.20
87449		<1%	181	$983.59
86001		<1%	462	$923.39
86308		<1%	373	$913.44
86359		<1%	89	$905.04
87276		<1%	115	$879.81
87275		<1%	115	$878.67
84305		<1%	95	$791.84
82951		<1%	247	$753.50
86593		<1%	327	$681.99
84132		<1%	513	$656.17
86357		<1%	73	$604.17
86355		<1%	71	$604.17
82330		<1%	133	$499.60
87106		<1%	131	$496.03
86710		<1%	14	$487.96
83498		<1%	39	$449.94
86702		<1%	107	$443.90
86628		<1%	25	$442.63
80361		<1%	599	$435.98
85613		<1%	89	$387.51
84482		<1%	72	$337.20
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	12	$325.00
86777		<1%	90	$313.54
86701		<1%	107	$309.61
85240		<1%	82	$292.98
86778		<1%	87	$284.26
85245		<1%	60	$264.39
82552		<1%	31	$232.42
82610		<1%	49	$231.25
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	12	$228.72
82088		<1%	24	$218.03
85705		<1%	39	$216.50
80346		<1%	69	$213.86
85246		<1%	59	$208.14
82085		<1%	83	$198.87
85384		<1%	41	$190.94
86615		<1%	13	$184.89
83527		<1%	27	$179.61
87476		<1%	17	$172.08
82310		<1%	78	$165.88
85670		<1%	39	$144.48
85732		<1%	75	$135.70
84166		<1%	45	$128.16
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	398	$121.86
84080		<1%	14	$110.49
83993		<1%	12	$87.78
87220		<1%	131	$73.59
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	210	$70.38
84075		<1%	29	$68.51
81243		<1%	12	$59.95
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	179	$28.68
80069		<1%	15	$21.30
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	135	$16.56
82232		<1%	13	$7.28
84295		<1%	19	$3.94
81003		<1%	20	$1.47
82140		0%	13	$0.00
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	13	$0.00
99080		0%	24	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPATEL, RUPEN (PRESIDENT)

Parent organizationMATRIX PERSONNEL SOLUTIONS INC.